Tasosartan
From Wikipedia, the free encyclopedia
Tasosartan
|
|
Systematic (IUPAC) name | |
2,4-dimethyl-8-[ [4-[2-(2H-tetrazol-5-yl)phenyl]phenyl]methyl]-5,6-dihydropyrido[6,5-d]pyrimidin-7-one | |
Identifiers | |
CAS number | ? |
ATC code | C09 |
PubChem | |
Chemical data | |
Formula | C23H21N7O |
Mol. mass | 411.459 g/mol |
Pharmacokinetic data | |
Bioavailability | ? |
Metabolism | ? |
Half life | ? |
Excretion | ? |
Therapeutic considerations | |
Pregnancy cat. |
? |
Legal status | |
Routes | ? |
Tasosartan is an angiotensin II receptor antagonist.
|